Track topics on Twitter Track topics that are important to you
Digital therapeutics provider Voluntis has secured market authorisation from the US Food and Drug Administration (FDA) for its Oleena software for oncology-related symptoms management and remote patient monitoring.
The post Voluntis gets FDA marketing approval for Oleena digital therapeutic appeared first on NS Medical Devices.
Original Article: Voluntis gets FDA marketing approval for Oleena digital therapeuticNEXT ARTICLE
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...